Debra L. Ondeyka

1.3k total citations
9 papers, 443 citations indexed

About

Debra L. Ondeyka is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Debra L. Ondeyka has authored 9 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Debra L. Ondeyka's work include Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Debra L. Ondeyka is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Renin-Angiotensin System Studies (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Debra L. Ondeyka collaborates with scholars based in United States. Debra L. Ondeyka's co-authors include Nathan B. Mantlo, Peter K. S. Siegl, Victor J. Lotti, Raymond S.L. Chang, William J. Greenlee, Prasun K. Chakravarty, Kristie A. Faust, Terry W. Schorn, Arthur A. Patchett and H.V. Strout and has published in prestigious journals such as Circulation, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Debra L. Ondeyka

9 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debra L. Ondeyka United States	7	232	185	120	80	46	9	443
W. J. GREENLEE United States	13	296 1.3×	190 1.0×	252 2.1×	74 0.9×	16 0.3×	21	573
Wolfgang Wostl Switzerland	9	279 1.2×	193 1.0×	138 1.1×	122 1.5×	17 0.4×	9	545
Karen M. Zimmerman United States	8	108 0.5×	109 0.6×	97 0.8×	104 1.3×	109 2.4×	11	368
NICHOLAS B. LYDON Switzerland	6	274 1.2×	193 1.0×	55 0.5×	102 1.3×	11 0.2×	9	434
Matthias Goebel Germany	15	270 1.2×	131 0.7×	201 1.7×	96 1.2×	31 0.7×	22	527
Sumaira Umbreen Germany	10	191 0.8×	76 0.4×	126 1.1×	48 0.6×	24 0.5×	14	423
Elaine M. Marino United States	7	205 0.9×	271 1.5×	100 0.8×	188 2.4×	21 0.5×	7	529
Christopher L. Heran United States	14	121 0.5×	162 0.9×	48 0.4×	16 0.2×	46 1.0×	22	503
Charlotta Wallinder Sweden	14	387 1.7×	434 2.3×	105 0.9×	217 2.7×	23 0.5×	19	692
Yumi Sakane Switzerland	12	222 1.0×	199 1.1×	129 1.1×	85 1.1×	18 0.4×	22	572

Countries citing papers authored by Debra L. Ondeyka

Since Specialization

Citations

This map shows the geographic impact of Debra L. Ondeyka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra L. Ondeyka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra L. Ondeyka more than expected).

Fields of papers citing papers by Debra L. Ondeyka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra L. Ondeyka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra L. Ondeyka. The network helps show where Debra L. Ondeyka may publish in the future.

Co-authorship network of co-authors of Debra L. Ondeyka

This figure shows the co-authorship network connecting the top 25 collaborators of Debra L. Ondeyka. A scholar is included among the top collaborators of Debra L. Ondeyka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra L. Ondeyka. Debra L. Ondeyka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Chu, Lin, Linda Chang, Lawrence F. Colwell, et al.. (2012). Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(12). 4133–4138. 21 indexed citations

Huckle, William R., Marlene Drag, Rosemary C. McFall, et al.. (1996). Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis. Circulation. 93(5). 1009–1019. 52 indexed citations

Kivlighn, Salah D., Gloria J. Zingaro, Robert A. Gabel, et al.. (1995). In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for angiotensin AT2 receptors. European Journal of Pharmacology. 294(2-3). 439–450. 3 indexed citations

Ashton, Wallace T., Linda Chang, Nathan B. Mantlo, et al.. (1995). AT1/AT2-BALANCED ANGIOTENSIN II ANTAGONISTS. European Journal of Medicinal Chemistry. 30. 255s–266s. 5 indexed citations

Mantlo, Nathan B., Dooseop Kim, Debra L. Ondeyka, et al.. (1994). Imidazo[4,5-b]pyridine-based AT1 / AT2 angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 17–22. 25 indexed citations

Siegl, Peter K. S., R S Chang, Nathan B. Mantlo, et al.. (1992). In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 262(1). 139–144. 88 indexed citations

Mantlo, Nathan B., Prasun K. Chakravarty, Debra L. Ondeyka, et al.. (1991). Potent, orally active imidazo[4,5-b]pyridine-based angiotensin II receptor antagonists. Journal of Medicinal Chemistry. 34(9). 2919–2922. 135 indexed citations

Saperstein, Richard, Pasquale P. Vicario, H.V. Strout, et al.. (1989). Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Biochemistry. 28(13). 5694–5701. 96 indexed citations

Wu, Mingshu, A. W. DOUGLAS, Debra L. Ondeyka, et al.. (1985). Synthesis of N2-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-proline (Lisinopril). Journal of Pharmaceutical Sciences. 74(3). 352–354. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact